Douglas Lane & Associates LLC raised its position in Dow Chemical Company (The) (NYSE:DOW) by 3.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,044 shares of the basic materials company’s stock after buying an additional 527 shares during the period. Douglas Lane & Associates LLC’s holdings in Dow Chemical Company (The) were worth $1,075,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Jennison Associates LLC boosted its stake in shares of Dow Chemical Company (The) by 23.1% in the first quarter. Jennison Associates LLC now owns 2,487,443 shares of the basic materials company’s stock worth $158,052,000 after buying an additional 467,320 shares in the last quarter. Bremer Trust National Association boosted its stake in shares of Dow Chemical Company (The) by 4.9% in the first quarter. Bremer Trust National Association now owns 21,010 shares of the basic materials company’s stock worth $1,335,000 after buying an additional 983 shares in the last quarter. Grassi Investment Management boosted its stake in shares of Dow Chemical Company (The) by 0.4% in the first quarter. Grassi Investment Management now owns 114,251 shares of the basic materials company’s stock worth $7,260,000 after buying an additional 401 shares in the last quarter. Boston Advisors LLC boosted its stake in Dow Chemical Company (The) by 0.6% in the first quarter. Boston Advisors LLC now owns 137,814 shares of the basic materials company’s stock valued at $8,757,000 after buying an additional 804 shares during the period. Finally, Bollard Group LLC boosted its stake in Dow Chemical Company (The) by 8.8% in the first quarter. Bollard Group LLC now owns 89,528 shares of the basic materials company’s stock valued at $5,689,000 after buying an additional 7,213 shares during the period. Hedge funds and other institutional investors own 68.79% of the company’s stock.

Shares of Dow Chemical Company (NYSE:DOW) traded up 0.24% during trading on Friday, hitting $63.26. 4,990,267 shares of the stock were exchanged. The stock has a 50-day moving average of $64.62 and a 200 day moving average of $63.06. Dow Chemical Company has a 12-month low of $51.57 and a 12-month high of $67.50. The stock has a market cap of $77.40 billion, a P/E ratio of 27.09 and a beta of 1.13.

Dow Chemical Company (The) (NYSE:DOW) last posted its quarterly earnings data on Thursday, July 27th. The basic materials company reported $1.08 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.07. The business had revenue of $13.83 billion during the quarter, compared to the consensus estimate of $13.60 billion. Dow Chemical Company (The) had a net margin of 5.83% and a return on equity of 17.08%. The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.95 earnings per share. Equities analysts predict that Dow Chemical Company will post $4.08 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Monday, July 31st will be issued a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 2.91%. The ex-dividend date is Thursday, July 27th. Dow Chemical Company (The)’s payout ratio is currently 76.99%.

TRADEMARK VIOLATION WARNING: This report was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://theolympiareport.com/2017/08/12/douglas-lane-associates-llc-increases-stake-in-dow-chemical-company-the-nysedow-updated.html.

Several analysts have recently commented on the stock. Alembic Global Advisors set a $85.00 target price on shares of Dow Chemical Company (The) and gave the stock a “buy” rating in a research note on Thursday, July 27th. BidaskClub upgraded shares of Dow Chemical Company (The) from a “sell” rating to a “hold” rating in a research note on Wednesday, July 12th. Cowen and Company restated a “hold” rating and issued a $60.00 target price on shares of Dow Chemical Company (The) in a research note on Friday, July 14th. Zacks Investment Research cut shares of Dow Chemical Company (The) from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $76.00 target price on shares of Dow Chemical Company (The) in a research note on Thursday, July 6th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Dow Chemical Company (The) has a consensus rating of “Buy” and an average target price of $71.42.

About Dow Chemical Company (The)

Institutional Ownership by Quarter for Dow Chemical Company (The) (NYSE:DOW)

Receive News & Ratings for Dow Chemical Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.